Strategies to adapt adenoviral vectors for targeted delivery

Annals of the New York Academy of Sciences

Volumn 886, Issue , 1999, Pages 158-171

  Curiel, David T ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; FOLIC ACID; IMMUNOGLOBULIN F(AB) FRAGMENT; INTEGRIN; RECEPTOR; RECEPTOR ANTIBODY; VIRUS RECEPTOR; VIRUS VECTOR;

ADENOVIRUS; CARCINOMA; CLONING VECTOR; CONFERENCE PAPER; GENE TARGETING; GENE THERAPY; NONHUMAN;

ADENOVIRIDAE; MURINAE;

EID: 0033427552     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09409.x     Document Type: Conference Paper

References (52)

1. 1. Anderson W.F. & J.C. Fletcher. 1980. Sounding boards. Gene therapy in human beings: When is it ethical to begin? N. Engl. J. Med. 303: 1293-1297.
2. 2. Brody S.L. & R.G. Crystal. 1994. Adenovirus-mediated in vivo gene transfer. Ann. N.Y. Acad. Sci. 716: 90-101.
3. 3. Tomko R.P., R. Xu & L. Philipson. 1997. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. 94: 3352-3356.
4. 4. Yang, Y., K.U. Jooss, Q. Su et al. 1996. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3: 137-144.
5. 5. Yang, Y., Q. Li, H.C. Ertl et al. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69: 2004-2015.
6. 6. Esandi, M.C., G.D. Van Someren, A.J. Vincent et al. 1997. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Gene Ther. 4: 280-287.
7. 7. Yee, D., S.E. McGuire, N. Brunner et al. 1996. Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer. Hum. Gene Ther. 7: 1251-1257.
8. 8. Bellon, G., L. Michel-Calemard et al. 1997. Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial. Hum. Gene Ther. 8: 15-25.
9. 9. Crystal, R.G., N.G. McElvaney, M.A. Rosenfeld et al. 1994. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8: 42-51.
10. 10. Knowles, M.R., K.W. Hohneker, Z. Zhou et al 1995. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis [see comments]. N. Engl. J. Med. 333: 823-831.
11. 11. Zabner, J., L.A. Couture, R.J. Gregory et al. 1993. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75: 207-216.
12. 12. Zabner, J., B.W. Ramsey, D.P., Meeker et al. 1996. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J. Clin. Invest. 97: 1504-1511.
13. 13. Goldman, M., Q. Su & J.M. Wilson. 1996. Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: Implications for gene therapy of cystic fibrosis. Gene Ther. 3: 811-818.
14. 14. Goldman, M.J. & J.M. Wilson. 1995. Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J. Virol. 69: 5951-5958.
15. 15. Grubb, B.R., R.J. Pickles, H. Ye et.al. 1994. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371: 802-806.
16. 16. Zabner, J., P. Freimuth, A. Puga et al. 1997. Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. J. Clin. Invest. 100: 1144-1149.
17. 17. Cosset, F.L. & S.J. Russell. 1996. Targeting retrovirus entry. Gene Ther. 3: 946-956.
18. 18. Shenk, T. 1996. Adenoviridae: The viruses and their replication. In Fields Virology B.N. Fields, D.M. Knipe & P.M. Howley, Eds. 3rd Ed.: 2111-2148. Lippincott-Raven. Philadelphia.
19. 19. Bergelson, J.M., J.A.Cunningham, G. Droguett et al. 1997. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320-1333.
20. 20. Hong, S.S., L. Karayan, J. Tournier et al. 1997. Adenovirus type 5 fiber knob binds to MHC Class I alpha-2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 16: 2294-2306.
21. 21. Wickham, T.J., P. Mathias, D.A. Chereh et al. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319.
22. 22. Michael, S.I., C.H. Huang, M.U. Romer et al. 1993. Binding-incompetent adenovirus facilitates molecular conjugate-mediated gene transfer by the receptor-mediated endocytosis pathway. J. Biol. Chem. 268: 6866-6869.
23. 23. Douglas, J.T., B.E. Rogers, M.E. Rosenfeld et al. 1996. Targeted gene delivery by tropism-modified adenoviral vectors. Nat. Biotech. 14: 1574-1578.
24. 24. Weitman, S.D., R.H. Lark, L.R. Coney et al. 1992. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52: 3396-3401.
25. 25. Anderson, R.G., B.A. Kamen, K.G. Rothberg et al. 1992. Potocytosis: Sequestration and transport of small molecules by caveolae. Science 255: 410-411.
26. 26. Wickham, T.J., D.M. Segal, P.W. Roelvink et al. 1996. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70: 6831-6838.
27. 27. Watkins, S.J., V.V. Mesyanzhinov, L.P. Kurochkina et al. 1997. The adenobody approach to viral targeting: Specific and enhanced adenoviral gene delivery. Gene Ther. 4: 1004-1012.
28. 28. Murthy, U., A. Basu, U. et al. 1987. Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. Arch. Biochem. Biophys. 252: 549-560.
29. 29. Wersall, P., I. Ohlsson, P. Biberfeld et al. 1997. Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma. Cancer Immunol. Immunother. 44: 157-64.
30. 30. Goldman, C.K., B.E. Rogers, J.T. Douglas et al. 1997. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res. 57: 1447-1451.
31. 31. Wickham, T.J., G.M. Lee, J.A. Titus et al. 1997. Targeted adenovirus-mediated gene delivery to T cells via CD3. J. Virol. 71: 7663-7669.
32. 32. Schulick, A.H., K.D. Newman, R. Virmani et al. 1995. In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation 91: 2407-2414.
33. 33. Schulick, A.H., G. Dong, K.D. Newman et al. 1995. Endothelium-specific in vivo gene transfer. Circ. Res. 77: 475-485.
34. 34. Elshami, A.A., J.W. Cook, K.M. Amin et al. 1997. The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivo. Cancer Gene Ther. 4: 213-221.
35. 35. Zinn, K.R., C. Smyth, H.-G. Liu et al. 1998. Imaging and tissue biodistribution of 99-m-Tc-labeled adenovirus knob (serotype 5). Gene Ther. 5. In press.
36. 36. Krasnykh, V.N., G.V. Mikheeva, J.T. Douglas et al. 1996. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J. Virol. 70: 6839-6846.
37. 37. Graham, F. & L. Prevec. 1991. Manipulation of adenovirus vectors. In Methods in Molecular Biology. E.J. Murray & J.M. Walker, Eds. Vol. 7. Gene Transfer and Expression Techniques.: 109-129. Humana Press. Clifton, NJ.
38. 38. Stevenson, S.C., M. Rollence, J. Marshallneff et. al. 1997. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J. Virol. 71: 4782-4790.
39. 39. Novelli, A. & P.A. Boulanger. 1991. Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber. Virology 185: 365-376.
40. 40. Michael, S.I., J.S. Hong, D.T. Curiel et al. 1995. Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther. 2: 660-668.
41. 41. Fancy, D.A., K. Melcher, S.A. Johnston et al. 1996. New chemistry for the study of multiprotein complexes: the six-histidine tag as a receptor for a protein crosslinking reagent. Chem. Biol. 3: 551-559.
42. 42. Wickham, T.J., E. Tzeng, L.L. Shears et al. 1997. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71: 8221-8229.
43. 43. Xia, D., L. Henry, R.D. Gerard et al. 1995. Structure of the receptor binding domain of adenovirus type 5 fiber protein. In The Molecular Repertoire of Adenoviruses 1. W. Doerfler & P. Bohm, Eds.: 39-46. Springer-Verlag. Berlin.
44. 44. Xia, D., L.J. Henry, R.D. Gerard et al. 1994. Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution. Structure 2: 1259-1270.
45. 45. Krasnykh, V., I. Dmitriev, G. Mikheeva et al. 1998. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J. Virol. In press.
46. 46. Chartier, C., E. Degryse, M. Gantzier et al. 1996. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70: 4805-4810.
47. 47. Pasqualini, R., E. Koivunen, E. Ruoslahti et al. 1997. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat. Biotech. 15: 542-546.
48. 48. Hong, S.S. & P. Boulanger. 1995. Protein ligands of the human adenovirus type 2 outer capsid identified by biopanning of a phage-displayed peptide library on separate domains of wild-type and mutant penton capsomers. EMBO J. 14: 4714-4727.
49. 49. Wickham, T.J., M.E. Carrion & I. Kovesdi. 1995. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2: 750-756.
50. 50. Barry, M.A., W.J. Dower & S.A. Johnston. 1996. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat. Med. 2: 299-305.
51. 51. Pasqualini, R. & E. Ruoslahti. 1996. Organ targeting in vivo using phage display peptide libraries. Nature 380: 364-366.
52. 52. Neri, D., B. Carnemolla, A. Nissim et al. 1997. Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nat. Biotech. 15: 1271-1275.